Evidence map›Paper›PMID 36843178›Full record

ArticleRevista de neurologia2023

Rare RNF213 variant in adolescent with moyamoya disease.

I Cardoso, M Pinto, A Araújo, M Vila-Real

Open access · greenAbstract readCase Reports
In one paragraph

Article in Revista de neurologia, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

I CardosoCentro Hospitalar de Vila Nova de Gaia, Vila Nova de Gaia, Portugal.
M PintoCentro Hospitalar de Vila Nova de Gaia, Vila Nova de Gaia, Portugal.
A AraújoCentro Hospitalar de Vila Nova de Gaia, Vila Nova de Gaia, Portugal.
M Vila-RealCentro Hospitalar de Vila Nova de Gaia, Vila Nova de Gaia, Portugal.
Centro Hospitalar de Vila Nova de Gaia · PT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionMoyamoya disease is a progressive steno-occlusive disease of the major intracranial arteries. Affected individuals are at risk for intracranial hemorrhagic or ischemic stroke, cognitive impairment, and developmental delays. Several susceptibility genes have been identified. The p.R4810K variant in the RNF213 gene has been identified in 95% of patients with familial moyamoya disease. CASE REPORT: We present the case of a 15-year-old adolescent girl who presented with chief complaints of dysgraphia, lack of coordination in the right hand, with two months of evolution. Cerebral magnetic resonance imaging revealed several ischemic lesions with different rates of evolution and magnetic resonance angiography showed multiple subocclusive stenoses. In the study of the sequences of the coding regions and intronic flanking regions (±8 bp) of the RNF213 gene, the variant c.12185G>A, p.(Arg4062Gln) was detected in heterozygosity in the RNF213 gene. This result indicates that the patient is heterozygous for the c.12185G>A, p.(Arg4062Gln) variant in the RNF213 gene. The detected variant has already been reported in the literature as a founder variant in the Asian population, associated with moyamoya syndrome. This variant is described in ClinVar as a variant of unknown clinical significance? Furthermore, it is not described in population databases (dbSNP, ESP, gnomAD).

conclusionTo our knowledge, the p.(Arg406262Gln) variant has been reported in three Japanese moyamoya disease patients and one European. Therefore, our patient was the second European moyamoya disease patient with this variant identified.

Indexed as

Moyamoya DiseaseAdenosine TriphosphatasesAdolescentFemaleGenetic Predisposition to DiseaseHumansMagnetic Resonance AngiographyTranscription FactorsUbiquitin-Protein LigasesAdenosine TriphosphatasesRNF213 protein, humanTranscription FactorsUbiquitin-Protein Ligases

Identifiers

PMID36843178
PMCPMC10364028
OpenAlexW4322500172

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.